# A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

> **NCT00489151** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 70 (estimated)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** adefovir dipivoxil
- **DRUG:** lamivudine

## Key facts

- **NCT ID:** NCT00489151
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489151, "A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00489151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*